(Australia-NewsWire.Com, August 02, 2018 ) Nuclear Imaging Market was worth USD 11.89 Billion in 2018 and estimated to be growing at a CAGR of 8.87%, to reach USD 18.19 Billion by 2023. Primary factors for the increase of the market are growing use of SPECT and pet analysis in radiopharmaceuticals, expanded recognition of human beings for radiopharmaceuticals, and ready availability of radiopharmaceuticals.
Novel application including Alzheimer’s and usually increasing oncology utility phase additionally power the marketplace. Till now, SPECT imaging became the mainstream modality for nuclear medication programs like nuclear cardiology procedures. But, the fashion is soon going to flip upside down because of the global shortage of molybdenum-ninety nine isotopes which in turn will lead to scarcity of Technetium-99, that’s the daughter manufactured from molybdenum. As a result, PET imaging merchandise which includes hybrid PET-CT scanners holds an ability market length in coming years.
The comfort of the treatment with minimally invasive techniques draws extra sufferers toward radiopharmaceuticals mode of remedy as compared to chemotherapy. The elements that drive the Radiopharmaceuticals enterprise consist of increasing incidence of cardiac patients and adoption of clean imaging technique, with the assist of diagnostic gadgets such as PET and SPECT.
The factors that restrain the boom of the marketplace include supply shortages, logistical problems, and constrained range of trained medical employees, existence of radioisotopes, high capital funding, regulatory guidelines and repayment issues.
With one-fifth of the investments in health, the US leads the market for international nuclear imaging.
The major companies dominating the global Nuclear Imaging market are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (Healthcare Division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategic activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions